To assess the therapeutic potential of ANKRD1 in the context of mouse IRI‐AKI, first, we utilised rAAV9‐mediated ANKRD1 knockdown strategy to inhibit ANKRD1 expression in mouse kidneys suffered from IRI. The gene discussed is ANKRD1; the disease is acute kidney injury.